Pfizer building’s column scare tests Midtown East’s biggest conversion bet
All eyes were on Midtown East last week after steel columns buckled inside the Pfizer building conversion project, forcing evacuations at the site and nearby buildings on Tuesday. The structural failures at 235 East 42nd Street — where Nathan Berman’s MetroLoft Management and investor David Werner are converting the pharmaceutical firm’s former headquarters into 1,600 apartments — captured national headlines and sparked surprise among industry players, as well as a probe by the city’s Department of Investigation into their cause. Though the building has since been stabilized, its near-collapse — and the spotlight it attracted — also raises questions about […]
This article originally appeared on The Real Deal. Click here to read the full story.
Categories
Recent Posts

Eli Karp sues attorney Leo Jacobs for malpractice

London club operator buys Meatpacking industrial building
for $100M

Lender refuses to let Harry Macklowe off the hook for $14M
loan shortfall

Hochul taps developers to build $1B Hell’s Kitchen
towers

Pay Off Your Mortgage or Reinvest in Real Estate? What Makes
More Sense in Today’s Market?

If House Flipping is “Dead,” How Is She Flipping 10+ Houses
THIS Year?

Long-Term Rentals vs. Short-Term Rentals: Which Is Best for
Beginners?

Peter Fine eyes $70M for SoBro rental

Building Department inspecting other construction sites
after Pfizer Building debacle


